WAT WATERS CORP /DE/
Laboratory Analytical Instruments · NYSE · SEC CIK 1000697 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY7.0%
TTM net income YoY0.8%
TTM EPS YoY0.5%
Revenue 3-yr CAGR2.1%
Net income 3-yr CAGR-3.2%
Margins
Gross margin59.3%
Operating margin25.4%
Net margin20.3%
FCF margin17.1%
EBITDA margin28.1%
Returns
ROE29.3%
ROA13.3%
ROIC (approx.)22.6%
Asset turnover0.66x
Leverage & solvency
Liabilities / assets49.5%
Debt / equity0.37x
Current ratio1.73x
Interest coverage11.54x
Cash quality & payout
Operating cash flow / net income1.02x
Accruals ratio-0.2%
Payout ratio—
Capex / revenue3.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-10-03 | 2026Q22026-07-04 | 2026Q12026-04-04 | 2025Q4*2025-12-31 | 2025Q3*2025-09-30 | 2025Q32025-09-27 | 2025Q2*2025-06-30 | 2025Q22025-06-28 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.77B | $1.65B | $1.27B | $932.36M | $799.89M | $800.00M | $771.33M | $771.00M |
| Cost of revenue | — | — | — | $362.86M | $327.81M | — | $321.41M | — |
| Gross profit | — | — | — | $569.50M | $472.08M | — | $449.93M | — |
| R&D expense | $106.00M | $122.00M | $96.00M | $46.90M | $53.64M | $54.00M | $48.55M | $49.00M |
| SG&A expense | $398.00M | $405.00M | $387.00M | $240.01M | $214.23M | $214.00M | $201.26M | $198.00M |
| Operating income | $128.00M | -$86.00M | -$47.00M | $270.52M | $192.11M | $192.00M | $188.21M | $188.00M |
| Interest expense | $59.00M | $60.00M | $48.00M | $14.29M | $26.64M | $27.00M | $14.35M | $15.00M |
| Pretax income | $74.00M | -$141.00M | -$88.00M | $264.18M | $170.12M | $170.00M | $177.69M | $178.00M |
| Income tax | -$7.00M | -$5.00M | -$16.00M | $38.97M | $21.20M | $21.00M | $30.58M | $31.00M |
| Net income | $81.00M | -$136.00M | -$72.00M | $225.21M | $148.92M | $149.00M | $147.11M | $147.00M |
| EBITDA | $163.00M | -$51.00M | -$11.00M | — | — | $214.00M | — | $210.00M |
| EPS (basic) | 0.83 | -1.39 | -0.87 | 3.78 | 2.50 | 2.50 | 2.47 | 2.47 |
| EPS (diluted) | 0.82 | -1.39 | -0.87 | 3.77 | 2.50 | 2.50 | 2.47 | 2.47 |
| Weighted avg. shares (diluted) | 99.00M | 98.20B | 82.14B | — | 59.62M | 60.00M | 59.66M | 59.66B |
| Banking | ||||||||
| Net interest income | — | — | — | -$6.33M | — | -$22.00M | — | -$10.52M |
| Balance sheet | ||||||||
| Cash & equivalents | $593.00M | $539.00M | $462.00M | $588.00M | — | $459.00M | — | $367.00M |
| Receivables | $1.46B | $1.99B | $673.00M | $829.00M | — | $748.52M | — | $730.07M |
| Inventory | $1.32B | $1.38B | $1.50B | $572.00M | — | $572.94M | — | $540.75M |
| Current assets | $4.12B | $4.46B | $4.06B | $2.15B | — | $1.92B | — | $1.78B |
| PP&E, net | $1.46B | $1.49B | $1.52B | $642.00M | — | $636.96M | — | $645.27M |
| Goodwill | $9.37B | $9.42B | $9.32B | $1.34B | — | $1.34B | — | $1.34B |
| Intangibles | $8.29B | $8.52B | $8.78B | $558.00M | — | $570.77M | — | $579.13M |
| Total assets | $24.11B | $24.75B | $24.53B | $5.08B | — | $4.86B | — | $4.72B |
| Current liabilities | $2.18B | $2.40B | $2.27B | $1.24B | — | $1.25B | — | $1.02B |
| Long-term debt | $4.48B | $4.89B | $4.86B | $947.00M | — | $947.21M | — | $1.20B |
| Total debt | $4.48B | $4.89B | $4.86B | $947.00M | — | $947.21M | — | $1.20B |
| Total liabilities | $8.82B | $9.56B | $9.24B | $2.52B | — | $2.53B | — | $2.56B |
| Shareholders' equity | $15.29B | $15.20B | $15.29B | $2.56B | — | $2.33B | — | $2.16B |
| Net debt | $3.89B | $4.35B | $4.39B | $359.00M | — | $488.21M | — | $829.97M |
| Shares outstanding | 98.27M | 98.22M | 98.17M | 59.55M | — | 59.52M | — | 59.51M |
| Cash flow statement | ||||||||
| Operating cash flow | $117.00M | $201.00M | -$3.00M | $164.55M | — | $187.00M | — | $41.00M |
| Capital expenditure | $63.00M | $48.00M | $39.00M | $38.74M | — | $25.00M | — | $23.00M |
| Free cash flow | $54.00M | $153.00M | -$42.00M | $125.81M | — | $162.00M | — | $18.00M |
| Investing cash flow | -$113.00M | $2.00M | $95.00M | -$42.13M | — | -$25.00M | — | -$59.00M |
| Financing cash flow | $58.00M | -$124.00M | -$213.00M | $3.34M | — | -$67.00M | — | -$1.00M |
| Depreciation & amortization | $35.00M | $35.00M | $36.00M | $21.93M | — | $22.00M | — | $22.00M |
| Stock-based compensation | $22.00M | $25.00M | $20.00M | $14.50M | — | $14.00M | — | $13.00M |
| Share buybacks | $1.00M | $2.00M | $12.00M | $144,000 | — | $1.00M | — | $0 |
Free plan shows the latest 8 periods; Pro shows all 97 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.